{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:14:54Z","timestamp":1784157294365,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The without a time limitation. Most recent search was performed on 1st June 2022.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thorough history and physical examination are very important in view of multiple possible causes of anal pruritus. Most of the focus during examination is drawn on to the perianal region. A digital rectal examination and an anoscopy are essential. It is necessary aim of this narrative review is to overview the classification, diagnostics, possible treatment options and future perspective of anal pruritus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The search was performed by two authors (AD and MJ) independently in the following electronic databases: PubMed, EMBASE, Web of Science, Cochrane Library, CENTRAL and the Allied and Complementary Medicine Databases (AMED). Search was restricted to English language only to avoid moisture and the use of soaps in the perianal region. Furthermore, the patient should avoid certain foods and increase the intake of fiber. If the symptoms do not resolve, topical steroids, capsaicin (0.006%) and tacrolimus (0.1%) ointments may be used. For intractable cases, intradermal methylene blue injection might give a long-lasting symptom relief.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Anal pruritus is a long-term deteriorating quality of life issue. Most of the time it is a symptom with a difficult diagnosis. Thorough history and examination should be performed for the best possible treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01018-5","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T07:03:19Z","timestamp":1675321399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation, management and future perspectives of anal pruritus: a narrative review"],"prefix":"10.1186","volume":"28","author":[{"given":"Matas","family":"Jakubauskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrius","family":"Dulskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"1018_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0733-8635(18)30725-3","volume":"5","author":"R Hanno","year":"1987","unstructured":"Hanno R, Murphy P. Pruritus ani. Classif manag Dermatol Clin. 1987;5:811\u20136. https:\/\/doi.org\/10.1016\/S0733-8635(18)30725-3.","journal-title":"Classif manag Dermatol Clin"},{"key":"1018_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000289128","volume":"66","author":"A Laurent","year":"1997","unstructured":"Laurent A, Boucharlat J, Bosson JL, et al. Psychological assessment of patients with idiopathic pruritus ani. Psychother Psychosom. 1997;66:163\u20136. https:\/\/doi.org\/10.1159\/000289128.","journal-title":"Psychother Psychosom"},{"key":"1018_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.5114\/ada.2021.108906","volume":"38","author":"K Hadasik","year":"2021","unstructured":"Hadasik K, Arasiewicz H, Brzezi\u0144skaWcis\u0142o L. Assessment of the anxiety and depression among patients with idiopathic pruritus ani. Psychother. 2021;38:689\u201393. https:\/\/doi.org\/10.5114\/ada.2021.108906.","journal-title":"Psychother"},{"key":"1018_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-3-030-66049-9_17","volume-title":"The ASCRS textbook of colon and rectal surgery","author":"K Umanskiy","year":"2022","unstructured":"Umanskiy K, Messaris E, et al. Dermatology and Pruritus Ani. In: Steele SR, Hull TL, Hyman N, et al., editors. The ASCRS textbook of colon and rectal surgery. Berlin: Springer International Publishing; 2022. p. 311\u201322."},{"key":"1018_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/9781118441213","volume-title":"Dermatoses of Perineal and Perianal Skin In Rook\u2019s Textbook of Dermatology 9th Edition","author":"CEM Griffiths","year":"2016","unstructured":"Griffiths CEM, Barker J, Bleiker TO, et al. Dermatoses of Perineal and Perianal Skin In Rook\u2019s Textbook of Dermatology 9th Edition. 9th ed. Hoboken: Wiley Blackwell Publishing; 2016. p. 1131\u201311333.","edition":"9"},{"key":"1018_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1055\/s-0039-1687827","volume":"32","author":"AE Ortega","year":"2019","unstructured":"Ortega AE, Delgadillo X. Idiopathic pruritus ani and acute perianal dermatitis. Clin Colon Rectal Surg. 2019;32:327\u201332. https:\/\/doi.org\/10.1055\/s-0039-1687827.","journal-title":"Clin Colon Rectal Surg"},{"key":"1018_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/bjs.1800740710","volume":"74","author":"A Allan","year":"1987","unstructured":"Allan A, Ambrose NS, Silverman S, Keighley MR. Physiological study of pruritus ani. Br J Surg. 1987;74:576\u20139. https:\/\/doi.org\/10.1002\/bjs.1800740710.","journal-title":"Br J Surg"},{"key":"1018_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/bjs.1800810442","volume":"81","author":"R Farouk","year":"2005","unstructured":"Farouk R, Duthie GS, Pryde A, Bartolo DCC. Abnormal transient internal sphincter relaxation in idiopathic pruritus ani: physiological evidence from ambulatory monitoring. Br J Surg. 2005;81:603\u20136. https:\/\/doi.org\/10.1002\/bjs.1800810442.","journal-title":"Br J Surg"},{"key":"1018_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/BF02054410","volume":"37","author":"GL Daniel","year":"1994","unstructured":"Daniel GL, Longo WE, Vernava AM. Pruritus ani: causes and concerns. Dis Colon Rectum. 1994;37:670\u20134. https:\/\/doi.org\/10.1007\/BF02054410.","journal-title":"Dis Colon Rectum"},{"key":"1018_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1308\/003588408X317940","volume":"90","author":"S Siddiqi","year":"2008","unstructured":"Siddiqi S, Vijay V, Ward M, et al. Pruritus Ani. Annals. 2008;90:457\u201363. https:\/\/doi.org\/10.1308\/003588408X317940.","journal-title":"Annals"},{"key":"1018_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.gtc.2013.09.002","volume":"42","author":"YY Nasseri","year":"2013","unstructured":"Nasseri YY, Osborne MC. Pruritus ani. Gastroenterol Clin North Am. 2013;42:801\u201313. https:\/\/doi.org\/10.1016\/j.gtc.2013.09.002.","journal-title":"Gastroenterol Clin North Am"},{"key":"1018_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jaad.2004.04.039","volume":"52","author":"AD Cohen","year":"2005","unstructured":"Cohen AD, Vander T, Medvendovsky E, et al. Neuropathic scrotal pruritus. J Am Acad Dermatol. 2005;52:61\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2004.04.039.","journal-title":"J Am Acad Dermatol"},{"key":"1018_CR13","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/ijcp.12457","volume":"68","author":"B Havlickova","year":"2014","unstructured":"Havlickova B, Weyandt GH. Therapeutic management of anal eczema: an evidence-based review. Int J Clin Pract. 2014;68:1388\u201399. https:\/\/doi.org\/10.1111\/ijcp.12457.","journal-title":"Int J Clin Pract"},{"key":"1018_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.suc.2009.09.007","volume":"90","author":"KW Markell","year":"2010","unstructured":"Markell KW, Billingham RP. Pruritus ani: etiology and management. Surg Clin North Am. 2010;90:125\u201335. https:\/\/doi.org\/10.1016\/j.suc.2009.09.007.","journal-title":"Surg Clin North Am"},{"key":"1018_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/BF02553616","volume":"25","author":"LE Smith","year":"1982","unstructured":"Smith LE, Henrichs D, McCullah RD. Prospective studies on the etiology and treatment of pruritus ani. Dis Colon Rectum. 1982;25:358\u201363. https:\/\/doi.org\/10.1007\/BF02553616.","journal-title":"Dis Colon Rectum"},{"key":"1018_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.12968\/bjcn.2001.6.8.7058","volume":"6","author":"J Ibarra","year":"2001","unstructured":"Ibarra J. Threadworms: a starting point for family hygiene. Br J Community Nurs. 2001;6:414\u201320. https:\/\/doi.org\/10.12968\/bjcn.2001.6.8.7058.","journal-title":"Br J Community Nurs"},{"key":"1018_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/archderm.1973.01620190083022","volume":"107","author":"L Goldman","year":"1973","unstructured":"Goldman L, Kitzmiller KW. Perianal atrophoderma from topical corticosteroids. Arch Dermatol. 1973;107:611\u20132. https:\/\/doi.org\/10.1001\/archderm.1973.01620190083022.","journal-title":"Arch Dermatol"},{"key":"1018_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF02050307","volume":"36","author":"JM Jorge","year":"1993","unstructured":"Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36:77\u201397. https:\/\/doi.org\/10.1007\/BF02050307.","journal-title":"Dis Colon Rectum"},{"key":"1018_CR19","first-page":"222","volume-title":"Gordon and Nivatvongs\u2019 Principles and Practice of Surgery for the Colon, Rectum, and Anus","author":"DE Beck","year":"2018","unstructured":"Beck DE, Wexner SD, Rafferty JF. Perianal Dermatologic Disease. In: Gordon and Nivatvongs\u2019 Principles and Practice of Surgery for the Colon, Rectum, and Anus. 4th ed. New York: Thieme Medical Publishers; 2018. p. 222\u201337.","edition":"4"},{"key":"1018_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00508-006-0529-x","volume":"118","author":"B Kr\u00e4nke","year":"2006","unstructured":"Kr\u00e4nke B, Trummer M, Brabek E, et al. Etiologic and causative factors in perianal dermatitis: results of a prospective study in 126 patients. Wien Klin Wochenschr. 2006;118:90\u20134. https:\/\/doi.org\/10.1007\/s00508-006-0529-x.","journal-title":"Wien Klin Wochenschr"},{"key":"1018_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/j.gastro.2008.04.039","volume":"135","author":"P Maisonneuve","year":"2008","unstructured":"Maisonneuve P, Botteri E, Lowenfels AB. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology. 2008;135:710. https:\/\/doi.org\/10.1053\/j.gastro.2008.04.039.","journal-title":"Gastroenterology"},{"key":"1018_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/cod.12514","volume":"74","author":"MJ Abu-Asi","year":"2016","unstructured":"Abu-Asi MJ, White IR, McFadden JP, White JML. Patch testing is clinically important for patients with peri-anal dermatoses and pruritus ani. Contact Dermatitis. 2016;74:298\u2013300. https:\/\/doi.org\/10.1111\/cod.12514.","journal-title":"Contact Dermatitis"},{"key":"1018_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2340\/00015555-0305","volume":"87","author":"S St\u00e4nder","year":"2007","unstructured":"St\u00e4nder S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm Venereol. 2007;87:291\u20134. https:\/\/doi.org\/10.2340\/00015555-0305.","journal-title":"Acta Derm Venereol"},{"key":"1018_CR24","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.6.77","author":"HG Kuehn","year":"2009","unstructured":"Kuehn HG, Gebbensleben O, Hilger Y, Rohde H. Relationship between anal symptoms and anal findings. Int J Med Sci. 2009. https:\/\/doi.org\/10.7150\/ijms.6.77.","journal-title":"Int J Med Sci"},{"key":"1018_CR25","doi-asserted-by":"publisher","first-page":"038","DOI":"10.1055\/s-0035-1570391","volume":"29","author":"P Ansari","year":"2016","unstructured":"Ansari P. Pruritus ani. Clin Colon Rectal Surg. 2016;29:038\u201342. https:\/\/doi.org\/10.1055\/s-0035-1570391.","journal-title":"Clin Colon Rectal Surg"},{"key":"1018_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.12968\/bjon.2012.21.2.98","volume":"21","author":"N Tomi","year":"2012","unstructured":"Tomi N, Weiser R, Strohal R, Mittlboeck M. A liquid-film forming acrylate cream for the treatment of anal pruritus. Br J Nurs. 2012;21:98\u2013102. https:\/\/doi.org\/10.12968\/bjon.2012.21.2.98.","journal-title":"Br J Nurs"},{"key":"1018_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/ddg.14125","volume":"18","author":"G Weyandt","year":"2020","unstructured":"Weyandt G, Breitkopf C, Werner RN, et al. German S1 guidelines for the diagnosis and treatment of perianal dermatitis (anal eczema). J Deutsche Derma Gesell. 2020;18:648\u201357. https:\/\/doi.org\/10.1111\/ddg.14125.","journal-title":"J Deutsche Derma Gesell"},{"key":"1018_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/bjs.1800680409","volume":"68","author":"JA Murie","year":"1981","unstructured":"Murie JA, Sim AJ, Mackenzie I. The importance of pain, pruritus and soiling as symptoms of haemorrhoids and their response to haemorrhoidectomy or rubber band ligation. Br J Surg. 1981;68:247\u20139. https:\/\/doi.org\/10.1002\/bjs.1800680409.","journal-title":"Br J Surg"},{"key":"1018_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/archderm.1960.01580020109028","volume":"82","author":"MJ Brunner","year":"1960","unstructured":"Brunner MJ. Pruritus ani and anal hygiene. Arch Dermatol. 1960;82:267. https:\/\/doi.org\/10.1001\/archderm.1960.01580020109028.","journal-title":"Arch Dermatol"},{"key":"1018_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/pgmj.2003.013045","volume":"80","author":"MO Oztas","year":"2004","unstructured":"Oztas MO. Idiopathic perianal pruritus: washing compared with topical corticosteroids. Postgrad Med J. 2004;80:295\u20137. https:\/\/doi.org\/10.1136\/pgmj.2003.013045.","journal-title":"Postgrad Med J"},{"key":"1018_CR31","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/BF02236575","volume":"43","author":"E Shocket","year":"2000","unstructured":"Shocket E. Anal cleansing vs. irritation. Dis Colon Rectum. 2000;43:1176\u20137. https:\/\/doi.org\/10.1007\/BF02236575.","journal-title":"Dis Colon Rectum"},{"key":"1018_CR32","first-page":"348","volume":"70","author":"SL Jensen","year":"1988","unstructured":"Jensen SL. A randomised trial of simple excision of non-specific hypertrophied anal papillae versus expectant management in patients with chronic pruritus ani. Ann R Coll Surg Engl. 1988;70:348\u20139.","journal-title":"Ann R Coll Surg Engl"},{"key":"1018_CR33","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1517\/14656566.2010.484420","volume":"11","author":"T Patel","year":"2010","unstructured":"Patel T, Yosipovitch G. Therapy of pruritus. Expert Opin Pharmacother. 2010;11:1673\u201382. https:\/\/doi.org\/10.1517\/14656566.2010.484420.","journal-title":"Expert Opin Pharmacother"},{"key":"1018_CR34","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/gut.52.9.1233","volume":"52","author":"P Anand","year":"2003","unstructured":"Anand P. Capsaicin and menthol in the treatment of itch and pain: recently cloned receptors provide the key. Gut. 2003;52:1233\u20135. https:\/\/doi.org\/10.1136\/gut.52.9.1233.","journal-title":"Gut"},{"key":"1018_CR35","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00384-007-0325-8","volume":"22","author":"R Al-Ghnaniem","year":"2007","unstructured":"Al-Ghnaniem R, Short K, Pullen A, et al. 1% Hydrocortisone ointment is an effective treatment of pruritus ani: a pilot randomized controlled crossover trial. Int J Colorectal Dis. 2007;22:1463. https:\/\/doi.org\/10.1007\/s00384-007-0325-8.","journal-title":"Int J Colorectal Dis"},{"key":"1018_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaad.2011.05.024","volume":"66","author":"E Suys","year":"2012","unstructured":"Suys E. Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani. J Am Acad Dermatol. 2012;66:327\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2011.05.024.","journal-title":"J Am Acad Dermatol"},{"key":"1018_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1529-8019.2005.00033.x","volume":"18","author":"J Hercogov\u00e1","year":"2005","unstructured":"Hercogov\u00e1 J. Topical anti-itch therapy: topical anti-itch therapy. Dermatol Ther. 2005;18:341\u20133. https:\/\/doi.org\/10.1111\/j.1529-8019.2005.00033.x.","journal-title":"Dermatol Ther"},{"key":"1018_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2340\/00015555-0748","volume":"90","author":"RS Kirsner","year":"2010","unstructured":"Kirsner RS, Heffernan MP, Antaya R. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids. Acta Derm Venereol. 2010;90:58\u201364. https:\/\/doi.org\/10.2340\/00015555-0748.","journal-title":"Acta Derm Venereol"},{"key":"1018_CR39","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/gut.52.9.1323","volume":"52","author":"J Lysy","year":"2003","unstructured":"Lysy J. Topical capsaicin\u2014a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut. 2003;52:1323\u20136. https:\/\/doi.org\/10.1136\/gut.52.9.1323.","journal-title":"Gut"},{"key":"1018_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/codi.14997","volume":"22","author":"NE Samalavicius","year":"2020","unstructured":"Samalavicius NE, Klimasauskiene V, Dulskas A. Intradermal 1% methylene blue injection for intractable idiopathic pruritus ani\u2014a video vignette. Colorectal Dis. 2020;22:846\u20137. https:\/\/doi.org\/10.1111\/codi.14997.","journal-title":"Colorectal Dis"},{"key":"1018_CR41","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/BF02052324","volume":"33","author":"EB Eusebio","year":"1990","unstructured":"Eusebio EB, Graham J, Mody N. Treatment of intractable pruritus ani. Dis Colon Rectum. 1990;33:770\u20132. https:\/\/doi.org\/10.1007\/BF02052324.","journal-title":"Dis Colon Rectum"},{"key":"1018_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10151-012-0846-1","volume":"16","author":"NE Samalavicius","year":"2012","unstructured":"Samalavicius NE, Poskus T, Gupta RK, Lunevicius R. Long-term results of single intradermal 1 % methylene blue injection for intractable idiopathic pruritus ani: a prospective study. Tech Coloproctol. 2012;16:295\u20139. https:\/\/doi.org\/10.1007\/s10151-012-0846-1.","journal-title":"Tech Coloproctol"},{"key":"1018_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10151-019-01934-x","volume":"23","author":"JH Kim","year":"2019","unstructured":"Kim JH, Kim DH, Lee YP. Long-term follow-up of intradermal injection of methylene blue for intractable, idiopathic pruritus ani. Tech Coloproctol. 2019;23:143\u20139. https:\/\/doi.org\/10.1007\/s10151-019-01934-x.","journal-title":"Tech Coloproctol"},{"key":"1018_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1046\/j.1463-1318.2002.00329.x","volume":"4","author":"ID Botterill","year":"2002","unstructured":"Botterill ID, Sagar PM. Intra-dermal methylene blue, hydrocortisone and lignocaine for chronic, intractable pruritus ani. Colorect Dis. 2002;4:144\u20136. https:\/\/doi.org\/10.1046\/j.1463-1318.2002.00329.x.","journal-title":"Colorect Dis"},{"key":"1018_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3968278","volume":"2017","author":"D Fransiska","year":"2017","unstructured":"Fransiska D, Jeo WS, Moenadjat Y, Friska D. Methylene blue effectiveness as local analgesic after anorectal surgery: a literature review. Adv Med. 2017;2017:1\u20135. https:\/\/doi.org\/10.1155\/2017\/3968278.","journal-title":"Adv Med"},{"key":"1018_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.03.031","author":"BS Kim","year":"2022","unstructured":"Kim BS. The translational revolution of itch. Neuron. 2022. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.031.","journal-title":"Neuron"},{"key":"1018_CR47","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1111\/bph.15672","volume":"178","author":"L Misery","year":"2021","unstructured":"Misery L, Brenaut E, Pierre O, et al. Chronic itch: emerging treatments following new research concepts. Br J Pharmacol. 2021;178:4775\u201391. https:\/\/doi.org\/10.1111\/bph.15672.","journal-title":"Br J Pharmacol"},{"key":"1018_CR48","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2217\/imt-2020-0175","volume":"12","author":"K Fourzali","year":"2020","unstructured":"Fourzali K, Golpanian RS, Yosipovitch G. Dupilumab use in atopic dermatitis and beyond in skin diseases. Immunotherapy. 2020;12:1221\u201335. https:\/\/doi.org\/10.2217\/imt-2020-0175.","journal-title":"Immunotherapy"},{"key":"1018_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18221","author":"M Gael","year":"2022","unstructured":"Gael M, Adam T, Mariano-Bourin M, Bursztejn Ac. Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a systematic review of current evidence and analysis of response predictors. Acad Dermatol Venereol jdv. 2022. https:\/\/doi.org\/10.1111\/jdv.18221.","journal-title":"Acad Dermatol Venereol jdv"},{"key":"1018_CR50","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/jdv.15957","volume":"34","author":"A Calugareanu","year":"2020","unstructured":"Calugareanu A, Jachiet M, Tauber M, et al. Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients. J Eur Acad Dermatol Venereol. 2020;34:e74\u20136. https:\/\/doi.org\/10.1111\/jdv.15957.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1018_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2021.1880542","author":"J Jeon","year":"2021","unstructured":"Jeon J, Wang F, Badic A, Kim BS. Treatment of patients with chronic pruritus of unknown origin with dupilumab. J Dermatol Treat. 2021. https:\/\/doi.org\/10.1080\/09546634.2021.1880542.","journal-title":"J Dermatol Treat"},{"key":"1018_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/ddg.14678","volume":"20","author":"H Bonnekoh","year":"2022","unstructured":"Bonnekoh H, Butze M, Metz M. Characterization of the effects on pruritus by novel treatments for atopic dermatitis. J Deutsche Derma Gesell. 2022;20:150\u20136. https:\/\/doi.org\/10.1111\/ddg.14678.","journal-title":"J Deutsche Derma Gesell"},{"key":"1018_CR53","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s40265-021-01521-1","volume":"81","author":"YS Roh","year":"2021","unstructured":"Roh YS, Choi J, Sutaria N, et al. IL-31 inhibition as a therapeutic approach for the management of chronic pruritic dermatoses. Drugs. 2021;81:895\u2013905. https:\/\/doi.org\/10.1007\/s40265-021-01521-1.","journal-title":"Drugs"},{"key":"1018_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJMoa1917006","volume":"383","author":"K Kabashima","year":"2020","unstructured":"Kabashima K, Matsumura T, Komazaki H, Kawashima M. Trial of nemolizumab and topical agents for atopic dermatitis with pruritus. N Engl J Med. 2020;383:141\u201350. https:\/\/doi.org\/10.1056\/NEJMoa1917006.","journal-title":"N Engl J Med"},{"key":"1018_CR55","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1056\/NEJMoa1908316","volume":"382","author":"S St\u00e4nder","year":"2020","unstructured":"St\u00e4nder S, Yosipovitch G, Legat FJ, et al. Trial of nemolizumab in moderate-to-severe prurigo nodularis. N Engl J Med. 2020;382:706\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1908316.","journal-title":"N Engl J Med"},{"key":"1018_CR56","doi-asserted-by":"publisher","first-page":"e002838","DOI":"10.1136\/jitc-2021-002838","volume":"10","author":"G Levy","year":"2022","unstructured":"Levy G, Guglielmelli P, Langmuir P, Constantinescu S. JAK inhibitors and COVID-19. J Immunother Cancer. 2022;10:e002838. https:\/\/doi.org\/10.1136\/jitc-2021-002838.","journal-title":"J Immunother Cancer"},{"key":"1018_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","volume":"18","author":"Y Tanaka","year":"2022","unstructured":"Tanaka Y, Luo Y, O\u2019Shea JJ, Nakayamada S. Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. Nat Rev Rheumatol. 2022;18:133\u201345. https:\/\/doi.org\/10.1038\/s41584-021-00726-8.","journal-title":"Nat Rev Rheumatol"},{"key":"1018_CR58","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/rheumatology\/kez087","volume":"58","author":"K Bechman","year":"2019","unstructured":"Bechman K, Subesinghe S, Norton S, et al. A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis. Rheumatology. 2019;58:1755\u201366. https:\/\/doi.org\/10.1093\/rheumatology\/kez087.","journal-title":"Rheumatology"},{"key":"1018_CR59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/bjd.18898","volume":"183","author":"EL Simpson","year":"2020","unstructured":"Simpson EL, Lacour J-P, Spelman L, et al. Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. Br J Dermatol. 2020;183:242\u201355. https:\/\/doi.org\/10.1111\/bjd.18898.","journal-title":"Br J Dermatol"},{"key":"1018_CR60","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJMoa2019380","volume":"384","author":"T Bieber","year":"2021","unstructured":"Bieber T, Simpson EL, Silverberg JI, et al. Abrocitinib versus placebo or dupilumab for atopic dermatitis. N Engl J Med. 2021;384:1101\u201312. https:\/\/doi.org\/10.1056\/NEJMoa2019380.","journal-title":"N Engl J Med"},{"key":"1018_CR61","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/S0140-6736(21)00588-2","volume":"397","author":"E Guttman-Yassky","year":"2021","unstructured":"Guttman-Yassky E, Teixeira HD, Simpson EL, et al. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials. The Lancet. 2021;397:2151\u201368. https:\/\/doi.org\/10.1016\/S0140-6736(21)00588-2.","journal-title":"The Lancet"},{"key":"1018_CR62","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bjd.14871","volume":"175","author":"R Bissonnette","year":"2016","unstructured":"Bissonnette R, Papp KA, Poulin Y, et al. Topical tofacitinib for atopic dermatitis: a phase II a randomized trial. Br J Dermatol. 2016;175:902\u201311. https:\/\/doi.org\/10.1111\/bjd.14871.","journal-title":"Br J Dermatol"},{"key":"1018_CR63","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jaad.2019.12.015","volume":"82","author":"H Nakagawa","year":"2020","unstructured":"Nakagawa H, Nemoto O, Igarashi A, et al. Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study. J Am Acad Dermatol. 2020;82:823\u201331. https:\/\/doi.org\/10.1016\/j.jaad.2019.12.015.","journal-title":"J Am Acad Dermatol"},{"key":"1018_CR64","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jaad.2020.02.009","volume":"82","author":"BS Kim","year":"2020","unstructured":"Kim BS, Sun K, Papp K, et al. Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study. J Am Acad Dermatol. 2020;82:1305\u201313. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.009.","journal-title":"J Am Acad Dermatol"},{"key":"1018_CR65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jdin.2022.03.007","volume":"7","author":"S Elmariah","year":"2022","unstructured":"Elmariah S, Chisolm S, Sciascia T, Kwatra SG. Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: a review of basic science and clinical implications. JAAD Int. 2022;7:156\u201363. https:\/\/doi.org\/10.1016\/j.jdin.2022.03.007.","journal-title":"JAAD Int"},{"key":"1018_CR66","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5021\/ad.2016.28.2.159","volume":"28","author":"J Lee","year":"2016","unstructured":"Lee J, Shin JU, Noh S, et al. Clinical efficacy and safety of naltrexone combination therapy in older patients with severe pruritus. Ann Dermatol. 2016;28:159. https:\/\/doi.org\/10.5021\/ad.2016.28.2.159.","journal-title":"Ann Dermatol"},{"key":"1018_CR67","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1912770","volume":"382","author":"S Fishbane","year":"2020","unstructured":"Fishbane S, Jamal A, Munera C, et al. A phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med. 2020;382:222\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1912770.","journal-title":"N Engl J Med"},{"key":"1018_CR68","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s40265-021-01619-6","volume":"81","author":"ED Deeks","year":"2021","unstructured":"Deeks ED. Difelikefalin: first approval. Drugs. 2021;81:1937\u201344. https:\/\/doi.org\/10.1007\/s40265-021-01619-6.","journal-title":"Drugs"},{"key":"1018_CR69","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","volume":"25","author":"H Kumagai","year":"2010","unstructured":"Kumagai H, Ebata T, Takamori K, et al. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant. 2010;25:1251\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfp588.","journal-title":"Nephrol Dial Transplant"},{"key":"1018_CR70","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1159\/000484573","volume":"46","author":"VS Mathur","year":"2017","unstructured":"Mathur VS, Kumar J, Crawford PW, et al. A multicenter, randomized, double-blind, placebo-controlled trial of nalbuphine ER tablets for uremic pruritus. Am J Nephrol. 2017;46:450\u20138. https:\/\/doi.org\/10.1159\/000484573.","journal-title":"Am J Nephrol"},{"key":"1018_CR71","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/jdv.17816","volume":"36","author":"E Weisshaar","year":"2022","unstructured":"Weisshaar E, Szepietowski JC, Bernhard JD, et al. Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase. Acad Dermatol Venereol. 2022;36:453\u201361. https:\/\/doi.org\/10.1111\/jdv.17816.","journal-title":"Acad Dermatol Venereol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01018-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T07:13:40Z","timestamp":1675322020000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01018-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1018"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01018-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}